Last reviewed · How we verify

NCT07152275

Percussive Therapy in U19 Males: Flexibility, Balance, Jump

Completed NA Last updated 9 January 2026
What this trial tests

NA trial testing Percussive Therapy in Physical Inactivity in 60 participants. Completed in 8 January 2026.

Timeline
1 July 2025
Primary endpoint
1 November 2025
8 January 2026

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date1 July 2025
Primary completion1 November 2025
Estimated completion8 January 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 15 to 19, male only, with Physical Inactivity or Postural Balance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effects of percussive therapy on muscle flexibility, balance, and jump performance in licensed U19 football players and sedentary healthy males under 19. Percussive therapy will be applied to the hamstring muscles for 120 seconds. Flexibility, balance, and explosive strength will be assessed using the sit-and-reach test, Y-Balance Test, and vertical jump test, respectively. The study also aims to compare the therapy's effects between active and sedentary participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Inactivity

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07152275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing